Insomnia Chronic
2
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
On Market (1)
Approved therapies currently available
U
PIMAVANSERINApproved
pimavanserin
Unknown Companyoral
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Verona PharmaUK - London
1 programDigital Health Technology for Chronic InsomniaN/A1 trial
Active Trials
M&
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Acadia PharmaceuticalsPimavanserin
Verona PharmaDigital Health Technology for Chronic Insomnia
Merck & Co.lumbar puncture
Clinical Trials (3)
Total enrollment: 80 patients across 3 trials
Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept
Start: Dec 2022Est. completion: Dec 20230
Phase 4Withdrawn
Assessment of Usability and Preliminary Effectiveness of a Digital Sleep Aid in an Italian Sample
Start: Mar 2025Est. completion: Mar 202650 patients
N/ARecruiting
Chronic Insomnia and CSF Markers of Dementia
Start: Jan 2019Est. completion: Oct 202330 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 80 patients
3 companies competing in this space